Stock IMMNOV IMMUNOVIA AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Immunovia AB

Equities

IMMNOV

SE0006091997

Real-time Estimate Cboe Europe
Other stock markets
 01:08:51 02/05/2024 pm IST 		5-day change 1st Jan Change
2.065 SEK +1.72% Intraday chart for Immunovia AB +8.93% +17.66%
29/04 Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024
29/04 Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunovia Appoints Lisa Ford as Clinical Laboratory Director
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Immunovia AB Announces Positive Results from the Model-Development Study for Its Next-Generation Pancreatic Cancer Detection Test
Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test
Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study
Immunovia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Immunovia AB Reports Earnings Results for the Full Year Ended December 31, 2023
Immunovia AB Elects Melissa Farina and Valerie Bogdan-Powers as New Board Members
Immunovia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Immunovia Shares Surge on Discovery Study for New Pancreatic Cancer Test
Immunovia Successfully Completes Discovery Phase of Next-Generation Test Development
Immunovia AB Announces Board Appointments
Immunovia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Sweden's Immunovia Redirects Resources Towards Development of New Pancreatic Cancer Detection Test
Immunovia AB Announces Board Changes
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2023
Immunovia AB Announces Board Changes
Philipp Von Hugo Resigns from Immunovia's Board at His Own Request
Immunovia Names US Head as New Global CEO
Immunovia AB Appoints New CEO
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMMNOV Stock
  4. News Immunovia AB
  5. Other languages